[Drug-induced valvular heart disease].
Blaschke
D
D
Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Medizinische Klinik mit Schwerpunkt Kardiologie, Augustenburger Platz 1, 13353 Berlin, Germany. daniela.blaschke@charite.de
Rolf
S
S
Parwani
A S
AS
Huemer
M
M
Dietz
R
R
Garbe
E
E
Haverkamp
W
W
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D002276:Carcinoid Tumor / Q000150:complications; D018491:Dopamine Agonists / Q000009:adverse effects; D004876:Ergot Alkaloids / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000139:chemically induced*; D006801:Humans; D012701:Serotonin / Q000502:physiology; D018490:Serotonin Agents / Q000009:adverse effects
D000316:Adrenergic alpha-Agonists; D018491:Dopamine Agonists; D004876:Ergot Alkaloids; D018490:Serotonin Agents; D012701:Serotonin